Lucía Boix-Palop - Concepedia

Author

Lucía Boix-Palop

Also Known As

Beatriz Dietl, Boix-Palop, Lucia, Cristina Badía, Data collection lead, Jonathan Fernández Suárez, José Ramon Arribas Lopez, L. Boix-Palop, Lucia Boix, Lucia Boix-Palop, Lucía Boix

101

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Mútua Terrassa Universidad de Sevilla Instituto de Biomedicina de Sevilla Hospital Universitario Virgen Macarena Universitat Internacional de Catalunya

About

Lucía Boix-Palop is an author at Mútua Terrassa specializing in medicine, clinical microbiology, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	286
2	Health Sciences	2	2	136
3	Public Health	2	2	51
4	Cardiothoracic Surgery	1	1	23
5	Emergency Medicine	1	1	23

Lucía Boix-Palop

Publications

809

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros, Journal of Antimicrobial Chemotherapy	2019	115
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients Marta Bodro, Carlota Gudiol, Carolina García‐Vidal, Supportive Care in Cancer Antimicrobial SusceptibilityCancer EpidemiologyAntibioticsHealth SciencesMedicine	2013	98
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant <i>Escherichia coli</i> Bacteremic Urinary Tract Infections Jesús Sojo-Dorado, Inmaculada López-Hernández, Clara Rosso-Fernández, JAMA Network Open	2022	82
Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score Javier Cobo, Esperanza Merino, Cristina Martínez, International Journal of Antimicrobial Agents Geih-cdi ScorePathogenesisHealthcare-associated InfectionHospital EpidemiologyInfection Control	2017	54
Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study Roberto Mateos Gaitán, Lucía Boix-Palop, Patricia Garcia, EP Europace	2020	51
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa : clinical and microbiological outcomes Beatriz Dietl, I. Sánchez, Paula Arcenillas, International Journal of Antimicrobial Agents Soft-tissue InfectionsAntimicrobial SusceptibilityHealth SciencesAntibioticsMicrobiological Outcomes	2017	38
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial Sara Grillo, Miquel Pujol, Josep M. Miró, Nature Medicine	2023	34
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci Carmen Hidalgo‐Tenorio, Svetlana Sadyrbaeva-Dolgova, Andrés Enríquez‐Gómez, International Journal of Antimicrobial Agents	2023	33
Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study) Pedro María Martínez Pérez-Crespo, Joaquín Felipe Lanz-García, José María Bravo-Ferrer, International Journal of Antimicrobial Agents Epidemiological TrendAntibioticsHealthcare-associated InfectionClinical EpidemiologyBloodstream Infections	2021	28
Multivalvular Endocarditis: A Rare Condition with Poor Prognosis Sara Álvarez-Zaballos, Víctor José González Ramallo, Eduard Quintana, Journal of Clinical Medicine Heart FailureCardiovascular DiseaseMultivalvular Infective EndocarditisPatient SafetyDiagnosis	2022	23

Page 1